Literature DB >> 26874703

Ablation for Persistent Atrial Fibrillation-Is There a Role for More Than PVI?

Jason M Lappe1, Michael J Cutler2, John D Day2, T Jared Bunch3,4,5.   

Abstract

OPINION STATEMENT: Persistent atrial fibrillation (AF) is a prevalent condition that can be difficult to treat medically, and an ablation strategy is often sought. Currently, the cornerstone of AF ablation strategies is pulmonary vein isolation (PVI). Unfortunately, the single procedure success rates are limited, particularly when long-term outcomes (>1 year) are considered. As a result, the most recent consensus statement recommends that in patients with persistent AF a more extensive ablation be considered. Many additive procedural approaches to PVI have been investigated. These include electrical compartmentalization of the atria with linear lesions (LLs), ablation of complex fractionated atrial electrograms (CFAEs), ablation of the dominant frequency (DF) signals, and focal impulse and rotor modulation (FIRM) ablation. Each of these approaches has demonstrated degrees of additive success when performed with a PVI in patients with persistent AF. This review provides an in-depth discussion of these techniques, their successes in treating persistent AF, and their shortcomings.

Entities:  

Keywords:  Arrhythmia; Atrial fibrillation; Pulmonary vein isolation

Year:  2016        PMID: 26874703     DOI: 10.1007/s11936-016-0437-y

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  57 in total

1.  Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study.

Authors:  Mélèze Hocini; Pierre Jaïs; Prashanthan Sanders; Yoshihide Takahashi; Martin Rotter; Thomas Rostock; Li-Fern Hsu; Frédéric Sacher; Sylvain Reuter; Jacques Clémenty; Michel Haïssaguerre
Journal:  Circulation       Date:  2005-12-13       Impact factor: 29.690

Review 2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

3.  Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation.

Authors:  Eugene Patterson; Sunny S Po; Benjamin J Scherlag; Ralph Lazzara
Journal:  Heart Rhythm       Date:  2005-06       Impact factor: 6.343

Review 4.  Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review.

Authors:  Anthony G Brooks; Martin K Stiles; Julien Laborderie; Dennis H Lau; Pawel Kuklik; Nicholas J Shipp; Li-Fern Hsu; Prashanthan Sanders
Journal:  Heart Rhythm       Date:  2010-01-22       Impact factor: 6.343

Review 5.  Catheter ablation for paroxysmal and persistent atrial fibrillation.

Authors:  Huai Sheng Chen; Jun Min Wen; Sheng Nan Wu; Jian Ping Liu
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

6.  Regional disparities of endocardial atrial activation in paroxysmal atrial fibrillation.

Authors:  P Jaïs; M Haïssaguerre; D C Shah; S Chouairi; J Clémenty
Journal:  Pacing Clin Electrophysiol       Date:  1996-11       Impact factor: 1.976

7.  Organized left atrial tachyarrhythmia during stepwise linear ablation for atrial fibrillation.

Authors:  Lihui Zheng; Yan Yao; Shu Zhang; Wensheng Chen; Kuijun Zhang; Fangzheng Wang; Xin Chen; Ding Sheng He; Alan H Kadish
Journal:  J Cardiovasc Electrophysiol       Date:  2008-11-21

8.  Real-time dominant frequency mapping and ablation of dominant frequency sites in atrial fibrillation with left-to-right frequency gradients predicts long-term maintenance of sinus rhythm.

Authors:  Felipe Atienza; Jesús Almendral; José Jalife; Sharon Zlochiver; Robert Ploutz-Snyder; Esteban G Torrecilla; Angel Arenal; Jérôme Kalifa; Francisco Fernández-Avilés; Omer Berenfeld
Journal:  Heart Rhythm       Date:  2008-10-22       Impact factor: 6.343

9.  Electrogram-guided substrate ablation with or without pulmonary vein isolation in patients with persistent atrial fibrillation.

Authors:  Heidi Luise Estner; Gabriele Hessling; Gjin Ndrepepa; Jinjin Wu; Tilko Reents; Stefanie Fichtner; Claus Schmitt; Christian V Bary; Christof Kolb; Martin Karch; Bernhard Zrenner; Isabel Deisenhofer
Journal:  Europace       Date:  2008-08-29       Impact factor: 5.214

10.  Dominant frequency differences in atrial fibrillation patients with and without left ventricular systolic dysfunction.

Authors:  Angel Arenal; Tomas Datino; Leonardo Atea; Felipe Atienza; Esteban González-Torrecilla; Jesús Almendral; Loreto Castilla; Pedro L Sánchez; Francisco Fernández-Aviles
Journal:  Europace       Date:  2009-04       Impact factor: 5.214

View more
  3 in total

1.  The association between left atrial stiffness and low-voltage areas of left atrium in patients with atrial fibrillation.

Authors:  Hideyuki Kishima; Takanao Mine; Eiji Fukuhara; Kenki Ashida; Masaharu Ishihara
Journal:  Heart Vessels       Date:  2019-05-02       Impact factor: 2.037

2.  The Values of Coronary Circulating miRNAs in Patients with Atrial Fibrillation.

Authors:  Guiyu Xu; Yuxia Cui; Zhenghua Jia; Yunan Yue; Shuixiang Yang
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

3.  Left atrial posterior wall isolation in conjunction with pulmonary vein isolation using cryoballoon for treatment of persistent atrial fibrillation (PIVoTAL): study rationale and design.

Authors:  Arash Aryana; Deep K Pujara; Shelley L Allen; James H Baker; Martin A Espinosa; Eric F Buch; Uma Srivatsa; Ethan Ellis; Kevin Makati; Marcin Kowalski; Sung Lee; Thomas Tadros; Tina Baykaner; Amin Al-Ahmad; André d'Avila; Luigi Di Biase; Kaoru Okishige; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2020-10-03       Impact factor: 1.900

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.